Opens in a new tab or window Itch may be more complex than it seems. A recent literature review presents a range of causes and treatments for chronic pruritus, including more novel options and a ...

Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

Zen types will tell you to accept the itch, to meditate on it, as you might do if you were in pain. These people have no idea ...

Early detection can significantly improve treatment outcomes, as the disease often progresses rapidly and can enter advanced stages with little warning. Engaging patients in discussions about risk ...

Obeticholic acid, which is marketed as Ocaliva as a treatment ... t have a favorable risk-benefit profile. The FDA doesn’t ...

Tinea is commonly known as ringworm, a fungal infection that can be found anywhere on the body. It gets its name because of the circular rash it causes. The name of the infection is determined by ...

It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally.

revealed factors that could significantly increase the risk of developing stomach cancer - Dr Ganesh Nagarajan highlighted the following signs of stomach cancer that one should watch out for - Dr ...

"The recent regulatory feedback from the EMA builds on the previous positive interactions with the FDA while providing a roadmap for TH104 for chronic pruritus ... under Risk Factors set forth ...

It was in 2018 – more than five decades after the itching, diagnosed as eczema, began – that his dermatologist suggested Martyn go on a clinical trial of a new treatment called dupilumab ...